| The anti-inflammatory cytokine IL-37 improves the NK cell-mediated anti-tumor response N Landolina, FR Mariotti, A Pelosi, V D’Oria, T Ingegnere, C Alicata, ... Oncoimmunology 13 (1), 2297504, 2024 | 4 | 2024 |
| TLR2/4 are novel activating receptors for SARS-CoV-2 spike protein on NK cells N Landolina, B Ricci, I Veneziani, C Alicata, FR Mariotti, A Pelosi, ... Frontiers in Immunology 15, 1368946, 2024 | | 2024 |
| Transition to a mesenchymal state in neuroblastoma may be characterized by a high expression of GD2 and by the acquisition of immune escape from NK cells S Di Matteo, MT Bilotta, A Pelosi, D Haas, T Theinert, G Weber, ... Frontiers in Immunology 15, 1382931, 2024 | | 2024 |
| CD34+DNAM-1brightCXCR4+ haemopoietic precursors circulate after chemotherapy, seed lung tissue and generate functional innate-like T cells and NK cells C Perrone, F Bozzano, MG Dal Bello, G Del Zotto, F Antonini, E Munari, ... Frontiers in Immunology 15, 1332781, 2024 | | 2024 |
| CD62Llow eosinophils proportion correlates with clinical parameters of asthma and chronic rhinosinusitis and in vivo/in vitro effect of mepolizumab on eosinophil … M Accinno, A Matucci, V Mecheri, E Vivarelli, P Parronchi, L Cosmi, ... ALLERGY 78, 2023 | | 2023 |
| Blood CD62Llow inflammatory eosinophils are related to the severity of asthma and reduced by mepolizumab A Vultaggio, M Accinno, E Vivarelli, V Mecheri, G Maggiore, L Cosmi, ... Allergy 78 (12), 3154-3165, 2023 | 5 | 2023 |
| Determining Endosomal Toll-Like Receptors Gene Expression in NK Cells After Stimulation with Specific Agonists C Alicata, I Veneziani, B Ricci, L Moretta, E Maggi Toll-Like Receptors: Methods and Protocols, 151-162, 2023 | | 2023 |
| Human toll-like receptor 8 (TLR8) in NK cells: implication for cancer immunotherapy I Veneziani, C Alicata, L Moretta, E Maggi Immunology Letters, 2023 | 4 | 2023 |
| The roles of different forms of IL-15 in human melanoma progression S Di Matteo, E Munari, PF Fiore, S Santopolo, C Sampaoli, A Pelosi, ... Frontiers in Immunology 14, 1183668, 2023 | 2 | 2023 |
| IL-1R8: A molecular brake of anti-tumor and anti-viral activity of NK cells and ILC FR Mariotti, D Supino, N Landolina, C Garlanda, A Mantovani, L Moretta, ... Seminars in Immunology 66, 101712, 2023 | 11 | 2023 |
| Legends of allergy and immunology: Sergio Romagnani E Maggi, P Parronchi, F Annunziato Allergy 78, 324-326, 2023 | | 2023 |
| High proportion of inflammatory CD62Llow eosinophils in blood and nasal polyps of severe asthma patients A Matucci, F Nencini, G Maggiore, F Chiccoli, M Accinno, E Vivarelli, ... Clinical & Experimental Allergy 53 (1), 78-87, 2023 | 24 | 2023 |
| The latest approach of immunotherapy with endosomal TLR agonists improving NK cell function: an overview I Veneziani, C Alicata, L Moretta, E Maggi Biomedicines 11 (1), 64, 2022 | 2 | 2022 |
| How the immune system responds to allergy immunotherapy I Veneziani, N Landolina, B Ricci, O Rossi, L Moretta, E Maggi Biomedicines 10 (11), 2825, 2022 | 5 | 2022 |
| A pathogenic integrated view explaining the different endotypes of asthma and allergic disorders E Maggi, P Parronchi, BG Azzarone, L Moretta Allergy 77 (11), 3267-3292, 2022 | 16 | 2022 |
| What we know and still ignore on COVID‐19 immune pathogenesis and a proposal based on the experience of allergic disorders E Maggi, BG Azzarone, GW Canonica, L Moretta Allergy 77 (4), 1114-1128, 2022 | 10 | 2022 |
| How the Immune System Responds to Allergy Immunotherapy. Biomedicines 2022, 10, 2825 I Veneziani, N Landolina, B Ricci, O Rossi, L Moretta, E Maggi s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| IL-1R8 silencing improves the anti-tumor function of freshly isolated human NK cells N Landolina, FR Mariotti, T Ingegnere, C Alicata, B Ricci, A Pelosi, ... Journal for Immunotherapy of Cancer 10 (3), 2022 | 6 | 2022 |
| Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56brightCD16− subset I Veneziani, C Alicata, A Pelosi, N Landolina, B Ricci, V D'Oria, A Fagotti, ... Journal for Immunotherapy of Cancer 10 (1), 2022 | 25 | 2022 |
| Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2. CAR T-cells in patients with neuroblastoma N Tumino, G Weber, F Besi, F Del Bufalo, V Bertaina, P Paci, L Quatrini, ... Journal of hematology & oncology 14, 1-7, 2021 | 50 | 2021 |
